# Regadenoson

NDC: 68083-175
Generic name: Regadenoson
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220712

FDA application: ANDA207320

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-175"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-175
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e4109f0-4875-4f8e-b70d-4055b3a785a3